2-(Bromomethyl)pyridine hydrobromide → HCID 59361445, compound
Reaction equation
[CH:1]12[CH2:10][CH:5]3[CH2:6][CH:7]([CH2:9][CH:3]([CH2:4]3)[CH:2]1[N:11]1[C:14](=[O:15])[C:13]([CH3:17])([CH3:16])[NH:12]1)[CH2:8]2.Br.Br[CH2:20][C:21]1[CH:26]=[CH:25][CH:24]=[CH:23][N:22]=1>>[CH3:16][C:13]1([CH3:17])[N:12]([CH2:20][C:21]2[CH:26]=[CH:25][CH:24]=[CH:23][N:22]=2)[N:11]([CH:2]2[CH:3]3[CH2:4][CH:5]4[CH2:6][CH:7]([CH2:8][CH:1]2[CH2:10]4)[CH2:9]3)[C:14]1=[O:15]Participants
3
Procedure
2-(Adamantan-2-yl)-4,4-dimethyl-1,2-diazetidin-3-one prepared in Process 3 of Example 12, and 2-(bromomethyl)pyridine hydrobromide were used for a similar reaction and treatment as Process 6 of Example 1, and the title compound was obtained as a pale yellow crystalline powder.
Workup
- customwere used for a similar reaction and treatment as Process 6 of Example 1
Sources & evidence
- ORD record
- ord-1a2b2aa3192a4f348727d4c3c64beac1
- Source dataset
- uspto-grants-2012_08
- Patent number
- US08252781B2
Reaction notes
Loading…